Early Phase 1 — Very small initial tests in humans, typically just a few people, to make sure the treatment is safe enough to study further.
Trial locations(4 sites)
United States
Moffitt Cancer Center, Tampa, Florida Oregon Health and Science University, Portland, Oregon University of Virginia Comprehensive Cancer Center, Charlottesville, Virginia Inova Schar Cancer Institute, Fairfax, Virginia